JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.40x

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Cash Flow Reinvestment Rate of 0.40x as of June 2025, reinvesting $1.03 Million (capex $1.03 Million ) from operating cash flow of $2.56 Million. Check ZJYL cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.40x
(Capex + Investments) / Operating CF

Total Reinvested

$1.03 Million
Capex + Investments

Operating Cash Flow

$2.56 Million
USD

Capital Expenditures

$1.03 Million
USD

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares across 5 annual periods. Explore ZJYL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)

Year-by-year capital reinvestment analysis for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares. For live market cap and broader valuation context, see ZJYL market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 3.54x $10.29 Million $2.90 Million $6.63 Million ▲ +42.3%
2023 2.49x $7.74 Million $3.11 Million $113.94K ▲ +2345.3%
2022 0.10x $161.07K $1.58 Million $40.17K ▼ -46.4%
2021 0.19x $1.11 Million $5.84 Million $42.88K ▼ -77.4%
2020 0.84x $2.10 Million $2.50 Million $142.32K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow